课题基金 / 基金详情

Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG

Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
利用睡眠和静息态脑电图进行阿尔茨海默病临床前诊断和纵向追踪的无创低成本生物标志物
批准号:
10177827
负责人:
BRADFORD C DICKERSON
金额:
$81.19万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2023-05-31

项目摘要

项目成果

BRADFORD C DICKERSON的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 本研究的目的是开发低成本、非侵入性的脑电生理生物标志物 在临床前和前驱阿尔茨海默病(AD)患者中, 睡眠和静息状态脑电图(EEG)。最近制定的“临床前”诊断标准 和“前驱”AD取决于β-淀粉样蛋白(Aβ)的测量以及脑结构和功能的变化, 是的。不幸的是,这些“黄金标准”生物标志物太昂贵(约3000美元/患者),侵入性或专业化 进行大规模的筛查因此,迫切需要新的具有成本效益的生物标志物,其是严格的, 与临床前AD的既定标准相关。越来越多的人认识到脑震荡是一种... 睡眠和静息状态下的EEG与潜在的AD病理生理学密切相关。公 已知AD痴呆与睡眠动力学紊乱和睡眠振荡改变有关。间隙 大脑Aβ通过大脑的胶质淋巴或“胶质淋巴”系统的作用, 眼动(NREM)睡眠,并且依赖于EEG慢振荡活动。大脑皮层的发电机 睡眠和静息状态EEG振荡,其可以使用源定位来估计,与大脑重叠 在AD中显示皮质变薄和功能连接丧失的区域。这些关系没有 在临床前或前驱AD中进行了广泛研究。因此,我们建议1)描述关系- 睡眠和静息状态EEG定量测量与神经影像学AD双相之间的关系 2)使用这些新的关系以及EEG中已知的AD相关变化, 基于EEG的AD预测因子,以及3)开发一个框架,将这些发现转化为低成本 (as低至20美元),高度可扩展的工具,用于筛选和跟踪临床前和前驱AD。
英文摘要
PROJECT SUMMARY The objective of this research is to develop low-cost, non-invasive, electrophysiological biomarkers of brain amyloid and neurodegeneration in patients with Preclinical and Prodromal Alzheimer's disease (AD) using the sleep and resting state electroencephalogram (EEG). Diagnostic criteria recently developed for “Preclinical” and “Prodromal” AD hinge upon measurements of beta-amyloid (Aβ) and changes in brain structure and func- tion. Unfortunately, these “gold standard” biomarkers are too expensive (~$3k/patient), invasive, or specialized for large-scale screening efforts. Thus, there is urgent need for novel cost-effective biomarkers that are rigor- ously linked to established criteria for Preclinical AD. There is a growing appreciation that brain oscillations ob- served in the sleep and resting state EEG are closely associated with underlying AD pathophysiology. It is well known that AD dementia is associated with disrupted sleep dynamics and altered sleep oscillations. Clearance of cerebral Aβ through the brain's glial lymphatic or “glymphatic” system occurs specifically during non-rapid eye movement (NREM) sleep, and is dependent on EEG slow oscillation activity. The cortical generators of sleep and resting state EEG oscillations, which can be estimated using source localization, overlap with brain regions that display cortical thinning and loss of functional connectivity in AD. These relationships have not been extensively studied in preclinical nor prodromal AD. We therefore propose to 1) characterize the rela- tionship between quantitative measures of sleep and resting state EEG and neuroimaging AD bi- omarkers, 2) use these novel relationships alongside known AD-related changes in the EEG to develop EEG-based predictors of AD, and 3) develop a framework for translating these findings into low-cost (as little as $20), highly-scalable tools for screening and tracking of preclinical and prodromal AD.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/sleep/zsac223
发表时间: 2023-01-11
期刊: Sleep
影响因子: 5.6
作者: []
通讯作者:
Quantifying statistical uncertainty in metrics of sleep disordered breathing.
量化睡眠呼吸障碍指标的统计不确定性。
DOI: 10.1016/j.sleep.2019.06.003
发表时间: 2020
期刊: Sleep medicine
影响因子: 4.8
作者: [Thomas,RobertJ, Chen,Shuqiang, Eden,UriT, Prerau,MichaelJ]
通讯作者: Prerau,MichaelJ
DOI: 10.1213/ane.0000000000004781
发表时间: 2020-11
期刊: Anesthesia and analgesia
影响因子: 5.7
作者: [Shao YR, Kahali P, Houle TT, Deng H, Colvin C, Dickerson BC, Brown EN, Purdon PL]
通讯作者: Purdon PL
Molecular Imaging Biomarkers in Dementia: Amyloid and tau PET imaging aids evaluation of patients suspected of having Alzheimer disease or other dementias.
痴呆症的分子成像生物标志物:淀粉样蛋白和 tau PET 成像有助于评估疑似患有阿尔茨海默病或其他痴呆症的患者。
DOI: --
发表时间: 2020
期刊: Practical neurology (Fort Washington, Pa.)
影响因子: --
作者: [Dickerson,Brad, Atri,Alireza]
通讯作者: Atri,Alireza
共 7 条
    Robust detection of atrophy over short intervals in AD and FTLD
    • 批准号:
      10633960
    • 项目类别:
    • 资助金额:
      $83.47万
    • 财政年份:
      2023
    • 负责人:
      BRADFORD C DICKERSON
    • 依托单位:
    ADRC Consortium for Clarity in ADRD Research Through Imaging
    • 批准号:
      10803806
    • 项目类别:
    • 资助金额:
      $3080.0万
    • 财政年份:
      2023
    • 负责人:
      BRADFORD C DICKERSON
    • 依托单位:
    Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
    • 批准号:
      10634041
    • 项目类别:
    • 资助金额:
      $251.6万
    • 财政年份:
      2023
    • 负责人:
      BRADFORD C DICKERSON
    • 依托单位:
    Neuromodulation of brain network function in preclinical and prodromal Alzheimer's Disease
    • 批准号:
      10589289
    • 项目类别:
    • 资助金额:
      $25.2万
    • 财政年份:
      2023
    • 负责人:
      BRADFORD C DICKERSON
    • 依托单位:
    海外基金